These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

360 related articles for article (PubMed ID: 16024643)

  • 1. The role of base excision repair in the sensitivity and resistance to temozolomide-mediated cell death.
    Trivedi RN; Almeida KH; Fornsaglio JL; Schamus S; Sobol RW
    Cancer Res; 2005 Jul; 65(14):6394-400. PubMed ID: 16024643
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Human methyl purine DNA glycosylase and DNA polymerase beta expression collectively predict sensitivity to temozolomide.
    Trivedi RN; Wang XH; Jelezcova E; Goellner EM; Tang JB; Sobol RW
    Mol Pharmacol; 2008 Aug; 74(2):505-16. PubMed ID: 18477668
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Temozolomide: mechanisms of action, repair and resistance.
    Zhang J; Stevens MF; Bradshaw TD
    Curr Mol Pharmacol; 2012 Jan; 5(1):102-14. PubMed ID: 22122467
    [TBL] [Abstract][Full Text] [Related]  

  • 4. N-methylpurine DNA glycosylase and DNA polymerase beta modulate BER inhibitor potentiation of glioma cells to temozolomide.
    Tang JB; Svilar D; Trivedi RN; Wang XH; Goellner EM; Moore B; Hamilton RL; Banze LA; Brown AR; Sobol RW
    Neuro Oncol; 2011 May; 13(5):471-86. PubMed ID: 21377995
    [TBL] [Abstract][Full Text] [Related]  

  • 5. BER, MGMT, and MMR in defense against alkylation-induced genotoxicity and apoptosis.
    Kaina B; Ochs K; Grösch S; Fritz G; Lips J; Tomicic M; Dunkern T; Christmann M
    Prog Nucleic Acid Res Mol Biol; 2001; 68():41-54. PubMed ID: 11554312
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Overcoming temozolomide resistance in glioblastoma via dual inhibition of NAD+ biosynthesis and base excision repair.
    Goellner EM; Grimme B; Brown AR; Lin YC; Wang XH; Sugrue KF; Mitchell L; Trivedi RN; Tang JB; Sobol RW
    Cancer Res; 2011 Mar; 71(6):2308-17. PubMed ID: 21406402
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Base excision repair intermediates induce p53-independent cytotoxic and genotoxic responses.
    Sobol RW; Kartalou M; Almeida KH; Joyce DF; Engelward BP; Horton JK; Prasad R; Samson LD; Wilson SH
    J Biol Chem; 2003 Oct; 278(41):39951-9. PubMed ID: 12882965
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pharmacologic disruption of base excision repair sensitizes mismatch repair-deficient and -proficient colon cancer cells to methylating agents.
    Liu L; Taverna P; Whitacre CM; Chatterjee S; Gerson SL
    Clin Cancer Res; 1999 Oct; 5(10):2908-17. PubMed ID: 10537360
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Acquired resistance to temozolomide in glioma cell lines: molecular mechanisms and potential translational applications.
    Zhang J; Stevens MF; Laughton CA; Madhusudan S; Bradshaw TD
    Oncology; 2010; 78(2):103-14. PubMed ID: 20357518
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of chemotherapy-induced DNA repair on oncolytic herpes simplex viral replication.
    Aghi M; Rabkin S; Martuza RL
    J Natl Cancer Inst; 2006 Jan; 98(1):38-50. PubMed ID: 16391370
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Potentiation of temozolomide cytotoxicity by inhibition of DNA polymerase beta is accentuated by BRCA2 mutation.
    Stachelek GC; Dalal S; Donigan KA; Campisi Hegan D; Sweasy JB; Glazer PM
    Cancer Res; 2010 Jan; 70(1):409-17. PubMed ID: 20028873
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mutations associated with base excision repair deficiency and methylation-induced genotoxic stress.
    Sobol RW; Watson DE; Nakamura J; Yakes FM; Hou E; Horton JK; Ladapo J; Van Houten B; Swenberg JA; Tindall KR; Samson LD; Wilson SH
    Proc Natl Acad Sci U S A; 2002 May; 99(10):6860-5. PubMed ID: 11983862
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Manipulation of base excision repair to sensitize ovarian cancer cells to alkylating agent temozolomide.
    Fishel ML; He Y; Smith ML; Kelley MR
    Clin Cancer Res; 2007 Jan; 13(1):260-7. PubMed ID: 17200364
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Nijmegen breakage syndrome protein (NBN) causes resistance to methylating anticancer drugs such as temozolomide.
    Eich M; Roos WP; Dianov GL; Digweed M; Kaina B
    Mol Pharmacol; 2010 Nov; 78(5):943-51. PubMed ID: 20729302
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Triazene compounds: mechanism of action and related DNA repair systems.
    Marchesi F; Turriziani M; Tortorelli G; Avvisati G; Torino F; De Vecchis L
    Pharmacol Res; 2007 Oct; 56(4):275-87. PubMed ID: 17897837
    [TBL] [Abstract][Full Text] [Related]  

  • 16. ATM regulates 3-methylpurine-DNA glycosylase and promotes therapeutic resistance to alkylating agents.
    Agnihotri S; Burrell K; Buczkowicz P; Remke M; Golbourn B; Chornenkyy Y; Gajadhar A; Fernandez NA; Clarke ID; Barszczyk MS; Pajovic S; Ternamian C; Head R; Sabha N; Sobol RW; Taylor MD; Rutka JT; Jones C; Dirks PB; Zadeh G; Hawkins C
    Cancer Discov; 2014 Oct; 4(10):1198-213. PubMed ID: 25100205
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Treatment with temozolomide and poly(ADP-ribose) polymerase inhibitors induces early apoptosis and increases base excision repair gene transcripts in leukemic cells resistant to triazene compounds.
    Tentori L; Turriziani M; Franco D; Serafino A; Levati L; Roy R; Bonmassar E; Graziani G
    Leukemia; 1999 Jun; 13(6):901-9. PubMed ID: 10360379
    [TBL] [Abstract][Full Text] [Related]  

  • 18. DNA polymerases beta and lambda mediate overlapping and independent roles in base excision repair in mouse embryonic fibroblasts.
    Braithwaite EK; Kedar PS; Stumpo DJ; Bertocci B; Freedman JH; Samson LD; Wilson SH
    PLoS One; 2010 Aug; 5(8):e12229. PubMed ID: 20805875
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mitochondrial targeting of human O6-methylguanine DNA methyltransferase protects against cell killing by chemotherapeutic alkylating agents.
    Cai S; Xu Y; Cooper RJ; Ferkowicz MJ; Hartwell JR; Pollok KE; Kelley MR
    Cancer Res; 2005 Apr; 65(8):3319-27. PubMed ID: 15833865
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Sensitization of human carcinoma cells to alkylating agents by small interfering RNA suppression of 3-alkyladenine-DNA glycosylase.
    Paik J; Duncan T; Lindahl T; Sedgwick B
    Cancer Res; 2005 Nov; 65(22):10472-7. PubMed ID: 16288039
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.